New drug aims to stop bleeding in emergency surgeries for blood thinner users
Disease control
Not yet recruiting
This Phase 3 trial tests whether a single dose of VMX-C001 can control bleeding better than usual care in 800 patients on blood thinners who need urgent high-risk surgery. Participants receive either VMX-C001 or standard treatment before their procedure, and experts will rate ble…
Phase: PHASE3 • Sponsor: VarmX B.V. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC